Skip to main content
. 2014 May 20;17(5):391–400. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2014.05.05

4.

厄洛替尼治疗114例晚期复治NSCLC肺癌患者的不良反应

The side effects of Erlotinib as second line treatment for 114 patient with recurrent non-small cell lung cancer

Toxicities Toxic side effects n (%)
1 2 3 4
Rash 36 29 8 0 73 (64.0)
Diarrhea 46 11 2 0 59 (51.8)
Anorexia 10 2 0 0 12 (10.5)
Fatigue 13 3 0 0 16 (14.0)
Hematologic 11 2 0 0 13 (11.4)
Hepatic 9 1 0 0 10 (8.8)
Interstitial lung disease 1 1 0 0 2 (1.8)